Cargando…
Suppression of Arrhythmia by Enhancing Mitochondrial Ca(2+) Uptake in Catecholaminergic Ventricular Tachycardia Models
Cardiovascular disease-related deaths frequently arise from arrhythmias, but treatment options are limited due to perilous side effects of commonly used antiarrhythmic drugs. Cardiac rhythmicity strongly depends on cardiomyocyte Ca(2+) handling and prevalent cardiac diseases are causally associated...
Autores principales: | Schweitzer, Maria K., Wilting, Fabiola, Sedej, Simon, Dreizehnter, Lisa, Dupper, Nathan J., Tian, Qinghai, Moretti, Alessandra, My, Ilaria, Kwon, Ohyun, Priori, Silvia G., Laugwitz, Karl-Ludwig, Storch, Ursula, Lipp, Peter, Breit, Andreas, Mederos y Schnitzler, Michael, Gudermann, Thomas, Schredelseker, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774336/ https://www.ncbi.nlm.nih.gov/pubmed/29354781 http://dx.doi.org/10.1016/j.jacbts.2017.06.008 |
Ejemplares similares
-
Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia
por: Jung, Christian B, et al.
Publicado: (2012) -
The antiarrhythmic compound efsevin directly modulates voltage‐dependent anion channel 2 by binding to its inner wall and enhancing mitochondrial Ca(2+) uptake
por: Wilting, Fabiola, et al.
Publicado: (2020) -
An optogenetic arrhythmia model to study catecholaminergic polymorphic ventricular tachycardia mutations
por: Fischer, Elisabeth, et al.
Publicado: (2017) -
Emerging Roles of Diacylglycerol-Sensitive TRPC4/5 Channels
por: Mederos y Schnitzler, Michael, et al.
Publicado: (2018) -
Catecholaminergic Polymorphic Ventricular Tachycardia
por: Abbas, Mohamed, et al.
Publicado: (2022)